To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• Arla Foods Ingredients signs acquisition agreement with the owners of Volac’s Whey Nutrition Business
• Tate & Lyle calls for focus on fibre and fortification
• The International Cheese & Dairy Expo weekly update
• The culture of yogurt
• dsm-firmenich opens applications for flavourist school’s class of 2025

The post Roundup: Ingredients appeared first on Dairy Industries International.

This proprietary school reflects dsm-firmenich’s commitment to advancing the art and science of flavour creation while meeting the global demand for foods and beverages that are healthier, more delicious, and better for people and planet.

The school’s two-year curriculum focuses on scientific expertise and creative know-how, equipping students with the skills needed to shape the future of flavours. With more than 80 industry experts guiding the programme, the school provides a dynamic learning environment that fosters cutting-edge expertise and innovation. In 2023, the school received over 1,600 applicants for the class of 2024. The 11 candidates will be offered a job within dsm-firmenich upon successful completion of the course.

The flavourist school is an example of dsm-firmenich’s long-standing commitment to continuous improvement and staying ahead of industry trends. The school is an integral part of dsm-firmenich’s flavourist academy, which for many decades has supported the career development of its community of flavourists – anticipating the expectations of its customers and building on more than 125 years of the company’s history. The flavourist school is led by Veronique le Gouellec, global director creation, with Patrick Salord, vice president global creation, as dean.

Veronique le Gouellec, global director creation at dsm-firmenich, says: “The flavourist school is a testament to our commitment to talent development. These passionate people trained by dsm-firmenich will play a crucial role in developing the next generation of great tasting foods and beverages, from delicious low-sugar drinks to sustainable dairy options, savoury snacks, and nutritious plant-based alternatives.”

Patrick Salord, vice president global creation at dsm-firmenich and dean of the flavourist school, comments: “It’s our ambition to shape the future of flavours and the best way to do that is to nurture talent. By investing in the training and development of the next generation of flavourists, we are contributing to our broader goal of creating healthier, more sustainable, and delicious foods and beverages for consumers around the world.”

For qualifications and more information on how to apply for the class of January 2025, visit dsm-firmenich’s careers page: Vacancies (dsm-firmenich.com)

The post dsm-firmenich opens applications for flavourist school’s class of 2025 appeared first on Dairy Industries International.

To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• FrieslandCampina predicts nutrition trends for 2024
• Kerry buys Chr Hansen lactase enzymes business
• dsm-firmenich secures 3-fucosyllactose market access in the European Union

The post Roundup: Ingredients appeared first on Dairy Industries International.

This milestone achievement follows the recent publication of a positive Scientific Opinion from the European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods and Food Allergens adopted on 27 April 2023. This opinion validates 3-FL produced by a derivative strain of Escherichia coli K-12 DH1 as a novel food in accordance with Regulation 2015/2283.

dsm-firmenich’s 3-FL, commercially marketed as GlyCare 3FL 9001, received authorization for use in a variety of foods, including infant formula, follow-on formula, conventional foods, food for special medical purposes and food supplements. Notably, dsm-firmenich’s 3-FL ingredient has been granted a higher maximum use level of 1.75 g/L for use in infant and follow-on formula, compared to levels approved previously for other 3-FL manufacturers, which ranged from 0.85 – 1.20 g/L. The distinction between different approved use levels in these food categories will remain in force for the duration of the five-year exclusive approval period that has been granted to dsm-firmenich’s 3-FL. Only after the exclusivity period ends, the highest approved use level will apply across all different sources of approved 3-FL. The authorization of the higher use level was made possible thanks to dsm-firmenich’s recent review on the mean concentration of HMOs in global pooled human milk, which included updated summary statistics for 3-FL.

Christoph Röhrig, head of the global HMO Regulatory Affairs team at dsm-firmenich, commented: “As a company devoted to creating healthier product choices, we’re excited to be at the forefront of advancements in early life nutrition with our science-backed 3-FL ingredient. 3-FL is one of the most abundant fucosylated HMOs in human milk, and scientific studies have demonstrated its promising potential to support immunity, gut health and potentially cognitive development.”

Marta Miks, senior regulatory & scientific affairs manager at dsm-firmenich, added: “The recent regulatory approval of 3-FL as a novel food in the EU means the ingredient joins our existing authorized portfolio of six HMOs in the region, including 2’-fucosyllactose (2′-FL), lacto-N-neotetraose (LNnT), difucosyllactose (DFL), lacto-N-tetraose (LNT), 3’-sialyllactose (3’-SL) sodium salt and 6’-sialyllactose (6’-SL) sodium salt. 3-FL stands out among other fucosylated HMOs as a distinctive component found in all maternal milks worldwide, because unlike most HMOs, 3-FL levels exhibit a gradual increase throughout the course of lactation. Addition of 3-FL may not only bring formula products closer to that of human breast milk, but also creates an opportunity for tailored innovation in age-appropriate solutions for early life nutrition. This is especially exciting, as emerging evidence indicates that HMOs may support the gut microbiota and immunity across the lifespan.

“As an end-to-end partner and the global leader in HMO regulatory approvals, we’re immensely proud to be leading the way in HMO innovation and look forward to supporting more customers in the EU with HMO customized solutions and expert services.”

To learn more about dsm-firmenich’s portfolio of next generation HMOs and the research behind these unique ingredients, visit: https://www.dsm.com/human-nutrition/en/products/hmos/hmos-for-early-life.html.

*Glycom A/S is ultimately controlled by DSM-Firmenich AG, registered in Kaiseraugst, Switzerland.

The post dsm-firmenich secures 3-fucosyllactose market access in the European Union appeared first on Dairy Industries International.

To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• Welcome to the Expo!
• Process Expo 2023 promises a host of new experiences, opportunities, and excitement
• ofi commissions new milk powder dryer in Malaysia
• SPX Flow introduces Plate Heat Exchanger FastFrame
• Yaskawa offers compact and powerful energy-saving palletising robots
• dsm-firmenich launches DelvoFresh Pioneer starter cultures

The post Roundup: Dairy Processing appeared first on Dairy Industries International.

With this generation of cultures, yogurt pH is extremely stable for up to 60 days in cold storage, representing a significant improvement compared to other cultures for mild yogurt recipes.

Consistency is key

The fermented milk market continues to grow and is expected to reach a value of approximately EUR 100 billion by 2027. With this growth comes an increased need to ensure consistency during production, mitigating unwanted variations in taste, texture and overall yogurt characteristics. Parallel to this, many consumers are turning to premium retail products, with 59% of people regularly enjoying indulgent treats such as mild yogurts. For fermented dairy manufacturers, the pressure is on to provide indulgent eating experiences and ensure taste and texture stay the same on shelf. As such, there is a need for a new generation of starter cultures that combine quality, consistency and pH stability.

Cultures fit for purpose

Designed by dsm-firmenich experts, DelvoFresh Pioneer starter cultures offer modern dairy manufacturers remarkable flexibility to create various mild yogurt recipes with optimal consistency in taste, texture and quality from batch-to-batch. Guaranteeing a delicious, smooth, creamy yogurt throughout its shelf life gives consumers the confidence they will enjoy a great tasting indulgence – every time.

DelvoFresh Pioneer cultures lead to significant and measurable reductions in post-acidification compared to other mild cultures. The significant pH stability is even more apparent with more challenging storage conditions, such as higher temperatures.

The new cultures are ideal for high-value recipes such as smooth, creamy yogurts and mild, reduced sugar yogurts with ‘better-for-you’ appeal.

“We’re investing heavily in culture development as we know the possibilities are near limitless, and more taste, texture and health benefits are out there to discover. These new cultures complement our fermented dairy toolkit of starter, bioprotective and probiotic cultures, enzymes, hydrocolloids and nutritional solutions,” comments Karoline Kjaerulff, global business development manager, Fermented Milk & Plant, dsm-firmenich. “The new DelvoFresh Pioneer cultures give yogurt manufacturers the tools needed to produce delicious, mild yogurt – consistently. The ideal pH stability enabled by these new cultures is what sets them apart, and for dairy manufacturers consistency and flexibility really are key to success. This launch was made possible by our biotechnology powerhouse which brings together renowned scientists, application experts and cutting-edge technology to solve the food industry’s biggest challenges.”

The DelvoPhage test kit delivers results in one hour – in everything from mesophilic applications like yogurt, quark and continental cheese to thermophilic applications, including mozzarella and US cheddar.

The DelvoPhage test kit gives you a more consistent production process for cheese and fermented products – increasing your production capacity and improving yield, while reducing product downgrades and waste.

Ideal for both cheese and fermented milk products, it can test for all cultures used in your production process– delivering the fastest results in the market – ‘on the spot’ at several steps in the production process. In fact, the Delvo®Phage test kit can boost your value in production by 5-10%.

To learn more about the full capabilities of the DelvoFresh Pioneer portfolio and its potential to optimize yogurt production, visit here.

The post dsm-firmenich launches DelvoFresh Pioneer starter cultures appeared first on Dairy Industries International.

To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• Fairfax Financial acquires equity interest in Meadow
• Arla Foods Ingredients and Zhongbai Xingye sign new agreement to advance Chinese nutrition business
• dsm-firmenich boosts HMO portfolio
• Novozymes and Arla Foods Ingredients join forces to harness power of precision fermentation
• Arla Foods Ingredients achieves first non-GMO project certification
• Meadow acquires Naked Foods

The post Roundup: Ingredients appeared first on Dairy Industries International.

For the first time globally, lacto-N-fucopentaose I with 2′-fucosyllactose (LNFP-I/2’-FL) can be commercialized in formula for infants and young children, as well as other food applications. The US is also the first market in which a HMO that is a pentasaccharide (LNFP-I), rather than a trisaccharide [e.g., 2’-FL, 3-fucosyllactose (3-FL), 3’-sialyllactose (3’-SL) or 6’-sialyllactose (6’-SL)] or tetrasaccharide (e.g., difucosyllactose (DFL), lacto-N-tetraose (LNT) or lacto-N-neotetraose (LNnT)], is commercially available.

dsm-firmenich’s hypoallergenic grade 2’-FL and LNnT ingredients are also GRAS for use in exempt hypoallergenic infant formula for term infants with cow milk protein allergy (CMPA).

These latest regulatory approvals will support greater accessibility to high-quality HMO products in the US and further strengthen the company’s end-to-end offering for early life nutrition innovation.

Specifically, LNFP-I/2’-FL is GRAS for use as an ingredient under the following intended conditions of use: up to 0.8 g/L in non-exempt term infant formula and formulas for young children, up to 1.2 g/L in other drinks for young children, up to 8.33g/kg in other foods for infants and young children; and up to a maximum range of 1.0 to 20 g/kg or g/L in a variety of conventional foods.^[i] Approvals at these maximum use levels were made possible thanks to dsm-firmenich’s recent review on the mean concentration of HMOs in global pooled human milk, which included updated summary statistics of LNFP-1.^[ii]

dsm-firmenich‘s hypoallergenic grade HMOs 2’-FL and LNnT – marketed as GlyCare 2FL 9000 HA and GlyCare LNnT 9000 HA – are GRAS for use in extensively hydrolyzed- or amino acid-based, exempt infant formula for term infants with CMPA.^[iii] The maximum use levels approved for 2’-FL and LNnT under this intended condition of use are  2.4 g/L and 0.6 g/L, respectively. While dsm-firmenich has previously achieved approval for use of these HMOs in several markets, as they are derived from lactose obtained from cow’s milk, stricter processes to control potential residual milk protein are applied for use in exempt hypoallergenic infant formula in the US.

Christoph Röhrig, head of HMO regulatory at dsm-firmenich, commented: “The GRAS status of LNFP-I/2’-FL for use in formula for infants and young children, as well as other food applications in the US, is a milestone for the use of this ingredient globally. What’s more, infants with cow’s milk protein allergies have now the opportunity to benefit from exempt formula supplemented with HMOs. Thanks to the approval for use of hypoallergenic grade 2’-FL and LNnT in the US, more infants are now able to enjoy the unique health benefits of HMOs.”

Marta Miks, Senior Regulatory & Scientific Affairs Manager at dsm-firmenich, added: “We are always looking for ways to enhance our HMO offering to help create brighter lives for babies around the world. Currently we are petitioning for exemption of our hypoallergenic grade 2’-FL and LNnT from food allergen labeling requirements of the Food, Drug and Cosmetic Act, as amended by Food Allergen Labeling and Consumer Protection Act (FALCPA). With the FDA’s ‘no questions’ response letter to the GRAS notifications, evaluation of the associated FALCPA exemption can now be completed, which will enable these HMOs to be commercialized in exempt infant formula in the US.”

“Moreover, approval for the use of LNFP-I/2’-FL in conventional foods in the US means we can also offer the unique benefits of HMOs to an adult audience. This is especially exciting, as emerging evidence indicates that HMOs may support the gut microbiota and immunity across the lifespan.^[iv]”

HMOs are a unique component of human breast milk with important benefits for immunity, gut health and potentially cognitive development. dsm-firmenich’s science-backed GlyCare HMO portfolio is available for use in more than 160 countries worldwide.

To learn more about dsm-firmenich’s portfolio of next generation HMOs and the research behind these unique ingredients, visit: https://www.dsm.com/human-nutrition/en/products/hmos/hmos-for-early-life.html

*Glycom A/S is ultimately controlled by DSM-Firmenich AG, registered in Kaiseraugst, Switzerland.

The post dsm-firmenich boosts HMO portfolio appeared first on Dairy Industries International.

To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome
• Remilk of Israel adds food industry executives to board
• Milk fat phospholipids reduce stress, says trial
• Chr Hansen secures EU approval for 6’-HMO
• Hochdorf rebrands for growth
• Westland Milk Products opens new lactoferrin plant in New Zealand

The post Roundup: Ingredients appeared first on Dairy Industries International.

About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
www.dsm-firmenich.com

About Adare Biome
Adare Biome develops, produces, and commercializes high-quality postbiotic solutions, including its pharmaceutical product, Lactéol®, which is marketed in almost 40 countries around the world. Its ingredients, including LBiome and LBiotix, are used for digestive health applications in human, pet, and production animals. Adare Biome is based in Houdan, France. More information can be found at www.adarebiome.com.

About Adare Pharma Solutions
Adare Pharma Solutions is a global, technology-driven CDMO providing product development through commercial manufacturing expertise, with a focus on oral dosage forms for the pharmaceutical industry. Adare’s specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 65 products sold by customers in more than 100 countries globally. More information can be found at www.adarepharmasolutions.com.

The post dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome appeared first on Dairy Industries International.

To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• Arla Food Ingredients launches infant formula ingredient
• EXOSOMM brings new bioactive ingredient to medical food space
• Lalcult Protect MC1 – a solution to control mould and yeast growth in dairy products
• Exberry from GNT unveils yellow food colouring for ice cream coating
• Dsm-firmenich launches as innovator in nutrition, health, and beauty

The post Roundup: Ingredients appeared first on Dairy Industries International.

Combining the essential, desirable, and sustainable

By creatively applying proven science and drawing on data-driven innovation capabilities as well as exceptional standards of operational excellence, dsm-firmenich seeks to tackle the tension between what society needs, what people individually want, and what the planet demands in the areas of nutrition, health, and beauty. By working closely together with customers to create what is essential for life as well as desirable for consumers yet simultaneously more sustainable for the planet, dsm-firmenich is poised to bring progress to life for billions of people around the world.

Geraldine Matchett and Dimitri de Vreeze, Co-CEOs of dsm-firmenich, commented: “Today marks a new beginning for us all that is the culmination of more than a century of ground-breaking science from two great companies. dsm-firmenich now stands out as a category of one, uniquely working at the intersection between what people individually want and what we collectively need, without costing the Earth. After all, what is essential has limited impact if it is not desirable, and that impact is not positive if it is not sustainable. And sustainable things that people don’t want or need don’t help much! We are truly global, built on an incredible foundation of proven world-class science with the broadest portfolio of nutrients, flavours, and fragrances. We are delighted to embark on this journey together as a single force for good as innovators in nutrition, health, and beauty.”

Structured for success

Dsm-firmenich is organized in four distinct high-performing businesses, rooted in complementary world-class scientific research and manufacturing excellence. Together they are uniquely positioned to help our customers realize their ambitions and address evolving consumer needs and wants.

• Perfumery & Beauty creates superior scents with proven benefits – always with the
  consumer in mind. Creating fragrances that smell amazing and make people feel even
  better, using the best and largest palette of natural, synthetic, and biotech ingredients.
• Taste, Texture & Health helps customers create food and beverage products that are
  delicious, nutritious, affordable, and sustainable. Providing enjoyment and nourishment
  for consumers, business success for customers, and better health for people and planet.
•  Health, Nutrition & Care provides people a way to look after their health by adding
  critical nutrients to diet. Driving medical innovation forward, speeding up recovery, and
  enhancing quality of life.
•  Animal Nutrition & Health delivers healthy animal proteins efficiently and sustainably,
  harnessing power of data to make animal farming practices more sustainable,
  productive, and transparent.

Delivering for all stakeholders

Dsm-firmenich is a purpose-led company where people and planet as well as financial success are at the core of its strategy. As a company formed of two growth companies that are also global sustainability leaders, dsm-firmenich is determined to keep growing its positive impact and keep raising the bar in helping to tackle climate change, protect nature, and care for people all along the value chain. Working together with customers and partners, the company strives to tackle the challenges of today and tomorrow while making a positive difference for the planet, and enhancing the lives of millions.

A new name and identity

To mark the launch of the new company, dsm-firmenich has revealed a new brand that captures the spirit of bringing two iconic organizations together in a merger of equals. The brand reflects the company’s purpose and values, and is the expression of a shared identity. The brand symbolizes the company’s mission to combine what is essential for life, desirable for consumers, and more sustainable for the planet. The purpose of dsm-firmenich is to bring progress to life, together with customers and partners, to achieve positive change and make a difference in the world.

Geraldine Matchett and Dimitri de Vreeze, Co-CEOs of dsm-firmenich, added: “We honour the legacy of DSM and Firmenich by taking the best of both companies in creating a fresh, new identity. It’s lively. It’s vibrant. It’s led by our purpose. Just like dsm-firmenich. This is the beginning of an exciting new time for our employees, our customers, and our partners as we go above and beyond in shaping a positive future for all and as we bring progress to life.”

Following the successful completion of the merger, Geraldine Matchett has decided this is the right time to further her career elsewhere and will move on, as of 1 September, in full alignment and with the thanks of the Board of Directors. Dimitri de Vreeze will be the dsm-firmenich CEO.

The post Dsm-firmenich launches as innovator in nutrition, health, and beauty appeared first on Dairy Industries International.

To submit a news item for inclusion, please contact Suzanne Christiansen at suzanne@bellpublishing.com or Maddy Barron at maddy@bellpublishing.com.

• New survey from Beneo reveals demand for scientifically proven prebiotics
• Arla Foods Ingredients brews up beverage innovation at Vitafoods Europe
• Emmi invests in goat milk powder
• Dsm-firmenich launches as innovators in nutrition, health, and beauty

The post Roundup: Ingredients appeared first on Dairy Industries International.